SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001867096-24-000041
Filing Date
2024-04-01
Accepted
2024-04-01 17:45:09
Documents
1
Period of Report
2024-03-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1712007900.html 4  
1 FORM 4 wk-form4_1712007900.xml 4 4509
  Complete submission text file 0001867096-24-000041.txt   5899
Mailing Address 712 COLLEGE AVENUE MENLO PARK CA 94025
Business Address
Kong Garheng (Reporting) CIK: 0001435183 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40880 | Film No.: 24811370

Mailing Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607
Business Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607 844-445-5704
Xeris Biopharma Holdings, Inc. (Issuer) CIK: 0001867096 (see all company filings)

IRS No.: 871082097 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)